↓ Skip to main content

Morbidity and Mortality of Cytoreduction with Intraperitoneal Chemotherapy: Outcomes from the ACS NSQIP Database

Overview of attention for article published in Annals of Surgical Oncology, August 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
93 Dimensions

Readers on

mendeley
51 Mendeley
Title
Morbidity and Mortality of Cytoreduction with Intraperitoneal Chemotherapy: Outcomes from the ACS NSQIP Database
Published in
Annals of Surgical Oncology, August 2013
DOI 10.1245/s10434-013-3223-z
Pubmed ID
Authors

Edmund K. Bartlett, Chelsey Meise, Robert E. Roses, Douglas L. Fraker, Rachel R. Kelz, Giorgos C. Karakousis

Abstract

Cytoreduction with intraperitoneal chemotherapy (IPC) for treatment of peritoneal surface malignancies is increasingly utilized. However, the described morbidity and mortality rates are based predominantly on the experience at high-volume centers. We analyzed the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database for a nationwide perspective on morbidity and mortality associated with IPC.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 10%
Student > Postgraduate 5 10%
Other 4 8%
Student > Ph. D. Student 3 6%
Student > Master 3 6%
Other 7 14%
Unknown 24 47%
Readers by discipline Count As %
Medicine and Dentistry 23 45%
Mathematics 1 2%
Chemistry 1 2%
Nursing and Health Professions 1 2%
Unknown 25 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2014.
All research outputs
#20,246,428
of 22,774,233 outputs
Outputs from Annals of Surgical Oncology
#5,484
of 6,452 outputs
Outputs of similar age
#175,402
of 199,927 outputs
Outputs of similar age from Annals of Surgical Oncology
#52
of 59 outputs
Altmetric has tracked 22,774,233 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,452 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 199,927 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.